Cannabis Use Disorder

Showing 26 - 50 of 67

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Psychotic Disorders, Cannabis Use Disorder, Cannabis Dependence Trial in Montréal (Contingency management)

Recruiting
  • Psychotic Disorders
  • +7 more
  • Contingency management
  • Montréal, Quebec, Canada
    Douglas Mental Health University Institute
Jun 30, 2022

Cannabis Dependence, PTSD, Cannabis Use Disorder Trial in Seattle (Prazosin Hydrochloride)

Recruiting
  • Cannabis Dependence
  • +2 more
  • Prazosin Hydrochloride
  • Seattle, Washington
    VA Puget Sound Health Care System
Jun 6, 2022

Cannabis Use Disorder Trial in Los Angeles (CUD-AMT, SUD-CBT)

Completed
  • Cannabis Use Disorder
  • CUD-AMT
  • SUD-CBT
  • Los Angeles, California
  • +1 more
May 16, 2022

Cannabis Use Disorder Trial in Canada (iCanChange)

Not yet recruiting
  • Cannabis Use Disorder
  • iCanChange
  • Calgary, Alberta, Canada
  • +4 more
Mar 31, 2022

Cannabis Use Disorder, Repetitive Transcranial Magnetic Stimulation Trial in Hong Kong (Repetitive Transcranial Magnetic

Not yet recruiting
  • Cannabis Use Disorder
  • Repetitive Transcranial Magnetic Stimulation
  • Repetitive Transcranial Magnetic Stimulation
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Mar 22, 2022

Cannabis Use Disorder Trial in United States (PF 04457845, Placebo Oral Tablet)

Recruiting
  • Cannabis Use Disorder
  • PF 04457845
  • Placebo Oral Tablet
  • New Haven, Connecticut
  • +3 more
Feb 9, 2022

Laboratory and Real World in Individuals With Cannabis Use

Active, not recruiting
  • Cannabis Use Disorder
  • Guided Imagery Laboratory Session
  • New Haven, Connecticut
    Yale Stress Center
Dec 7, 2021

Cannabis Use Disorder Trial in Charleston (Approach Bias Modification (ABM), Sham ABM, Psychosocial therapy for cannabis use

Recruiting
  • Cannabis Use Disorder
  • Approach Bias Modification (ABM)
  • +2 more
  • Charleston, South Carolina
    Medial University of South Carolina
Nov 16, 2021

Cannabis Use Disorder Trial in Barcelona (CANreduce, psychological support)

Recruiting
  • Cannabis Use Disorder
  • CANreduce
  • psychological support
  • Barcelona, Catalunya, Spain
    Juan-Ignacio Mestre-Pinto
Nov 5, 2021

in Utero Cannabis Exposure on Neonatal Brain Morphology and

Completed
  • Cannabis Use Disorder
  • +4 more
  • no intervention, this is a purely observational study
  • Aurora, Colorado
  • +1 more
Oct 25, 2021

Schizophrenia, Dual Diagnosis, Psychotic Disorder Trial in Lebanon, Burlington (Marijuana, Dronabinol, Placebo)

Completed
  • Schizophrenia
  • +3 more
  • Lebanon, New Hampshire
  • +1 more
Oct 11, 2021

Cannabis Use Disorder Trial in Charleston, Pickens (Varenicline, Placebo)

Recruiting
  • Cannabis Use Disorder
  • Charleston, South Carolina
  • +1 more
Oct 5, 2021

Cannabis Use Disorder Trial (Exercise, Video Control)

Not yet recruiting
  • Cannabis Use Disorder
  • Exercise
  • Video Control
  • (no location specified)
Oct 4, 2021

Cannabis Use Disorder Trial in New York (Clonazepam, Placebo)

Completed
  • Cannabis Use Disorder
  • New York, New York
    Substance Treatment Research Service (STARS) of Columbia Univers
Jul 15, 2021

Schizophrenia, Dual Diagnosis, Schizoaffective Disorder Trial in Lebanon (Dronabinol, Cannabis)

Completed
  • Schizophrenia
  • +4 more
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Jul 8, 2021

Cannabis Use Disorder, Attention-deficit/Hyperactivity Disorder Trial in New York (Adderall-XR, Matched )

Completed
  • Cannabis Use Disorder
  • Attention-deficit/Hyperactivity Disorder
  • New York, New York
    New York Psychiatric Institute
Mar 16, 2021

Maternal Marijuana Use and Fetal and Infant Outcome

Withdrawn
  • Cannabis Use Disorder
  • Pregnancy Related
  • Maternal-fetal monitoring
  • NICU Network Neurobehavioral Scale
  • Baltimore, Maryland
    Johns Hopkins Bayview Medical Center
Feb 15, 2021

Cannabis Use Disorder Trial in New York (Lorcaserin, Placebo oral capsule)

Terminated
  • Cannabis Use Disorder
  • New York, New York
    Columbia Substance Treatment and Research Service
Jan 12, 2021

Cannabis Use Disorder Trial in Kingston (Ondansetron 8mg, Haloperidol 0.05mg/kg, Haloperidol 0.1mg/kg)

Completed
  • Cannabis Use Disorder
  • Ondansetron 8mg
  • +2 more
  • Kingston, Ontario, Canada
  • +2 more
Dec 17, 2020

Cannabis Use Disorder, Cannabis Dependence Trial in Brussels (N-acetylcysteine, Placebo Oral Tablet, Magnetic Resonance Imaging)

Recruiting
  • Cannabis Use Disorder
  • Cannabis Dependence
  • Brussels, Belgium
    University Hospital Brussels
Dec 7, 2020

Bipolar I Disorder, Bipolar II Disorder, Cannabis Use Disorder Trial in Charleston (Gabapentin, Placebo Oral Capsule)

Completed
  • Bipolar I Disorder
  • +3 more
  • Charleston, South Carolina
    Medical University of South Carolina
Oct 21, 2020

Cannabis Use Disorder Trial in Toronto (Naltrexone 380 MG [Vivitrol], Motivational Enhancement Therapy and Cognitive Behavioral

Not yet recruiting
  • Cannabis Use Disorder
  • Naltrexone 380 MG [Vivitrol]
  • Motivational Enhancement Therapy and Cognitive Behavioral Therapy
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Sep 24, 2020

Cannabis Use Disorder, Cannabis Dependence, Continuous Trial in Baltimore (11C-OMAR, Cannabis)

Completed
  • Cannabis Use Disorder
  • Cannabis Dependence, Continuous
  • Baltimore, Maryland
    Johns Hopkins Bayview Medical Center
May 18, 2020

ADHD, Nicotine Dependence, Cannabis Use Disorder Trial in Denver (Bupropion, Placebo)

Completed
  • Attention Deficit Hyperactivity Disorder
  • +2 more
  • Denver, Colorado
    University of Colorado Denver, Adolescent Clinical Research
Dec 10, 2019

Cannabis Use Disorder Trial (Computerized Distress Intolerance Intervention, Computerized Healthy Behaviors Intervention)

Completed
  • Cannabis Use Disorder
  • Computerized Distress Intolerance Intervention
  • Computerized Healthy Behaviors Intervention
  • (no location specified)
Nov 20, 2019